Dow Up 1.05% Nasdaq Up 1.74%

CEL-SCI Corporation (CVM)

-NYSE MKT
0.70 Down 0.15(17.65%) 12:20PM EDT - Nasdaq Real Time Price
Prev Close:0.85
Open:0.72
Bid:0.70 x 200
Ask:0.70 x 200
1y Target Est:7.00
Beta:-0.73
Next Earnings Date:N/A
Day's Range:0.65 - 0.72
52wk Range:0.53 - 1.90
Volume:2,609,405
Avg Vol (3m):262,718
Market Cap:55.77M
P/E (ttm):N/A
EPS (ttm):-0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CVM

Comparison

Symbol% ChgMkt Cap
CVMDown 17.65%55.77M
CLDXDown 3.17%1.31B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):319.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-0.43
Quarterly EPS Est (Sep-14) :-0.10
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CEL-SCI Corporation is engaged in the research and development of drugs and vaccines. The company’s lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck ca... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback